Navigation Links
Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
Date:11/20/2007

ms," said Patty Kumbera, Chief Operating Officer, Outcomes Pharmaceutical Health Care(r). "We are excited to partner with ASCP to expand our network. ASCP members will join thousands of Outcomes Personal Pharmacists providing face to face MTM services, including comprehensive medication reviews, cost efficacy management, drug therapy problem resolution, and patient consultations."

"ASCP's MTM Provider Partners offer our members a unique path for providing clinical services in the community setting," said ASCP's Feather. "This has been a membership desire for some time, and we are pleased to add ASCP'S MTM Provider Partners to our roster of member benefits."

The American Society of Consultant Pharmacists, the recognized expert in geriatric pharmacotherapy, is the international professional association that provides leadership, education, advocacy, and resources to advance the practice of consultant and senior care pharmacy. ASCP's 8,000 members manage and improve drug therapy and improve the quality of life of geriatric patients and other individuals residing in a variety of environments, including nursing facilities, subacute care and assisted living facilities, psychiatric hospitals, hospice programs, and in-home and community-based care. Visit ASCP's Web site at http://www.ascp.com.


'/>"/>
SOURCE American Society of Consultant Pharmacists
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Continued Statin Use Boosts Post-Stroke Outcomes
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. QI projects may -- or may not -- improve patient safety and outcomes
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Bypass Off-Pump Boosts Womens Outcomes
7. Mayo Clinic study indicates medication for ADHD may help student outcomes
8. Experts Compare Colon Cancer Treatment Outcomes
9. Gene Chip Data Can Boost Cancer Outcomes
10. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
11. Studies suggest key correlation between lung cancer subtype and treatment outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... -- A study released this week showing that a grow...e chronic diseases shines a much-needed spotlight ...o one that focuses on primary and secondary preven...eader in disease prevention. , , (Logo: htt...OGO ) , , The study, conducted by Social &...
(Date:1/8/2009)...Tom Torlakson Introduces AB 89 , , SACRAMENTO, ... Lung Cancer Alliance-California (LCA-CA), hailed ...istrict) for his continued leadership in introduci...esearch. For the third consecutive year, legislat...considered in the California Legislature. , ,...
(Date:1/8/2009)...rtful comments, study suggests , , THUR...stimate how strongly they would react to racist ac...ercent of study participants at York University, i...t with a white person rather than a black one, eve...t the black person when he left the room. , "...
(Date:1/8/2009)...ewswire-FirstCall/ -- Hanger Orthopedic Group, Inc...ghout the fourth quarter of 2008 it acquired Maine...tain Orthotic-Prosthetics Center, Riessen,s Orthop...thotics & Prosthetics, and Orthopedic Rehabili...nt care centers to existing markets in Maine, Loui...
Breaking Medicine News(10 mins):Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2
...ission tomography (PET) scan images can successful...ollowing the cognitive behavior therapy in patient... prove that cognitive behavior therapy can bring a...l get long lasting results in patients like those ...
...rence of thyroid cancer may be detectable using a ...bin”(Tg) according to a study published by resear...ancer Center and Arthur G. James Cancer Hospital ...ndings were published June 21 online in the Journa...
...borderline ovarian tumors can still preserve their...of the largest study on women with borderline ovar...ity to have a child by getting only one ovary remo...ind of epithelial ovarian tumors. These tumors hav...
...h can now help the clinicians to predict which wou...d sores, also known as pressure sores or pressure ...n their beds in the hospital or at home without mu...r circulation problems and people with diabetes, w...
Other Medicine News:Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2
(Date:1/8/2009)...ated at the initial dose in an ongoing Phase Ib tr...line after three days , , Conference Call Today...re-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nas...st cohort of an ongoing Phase Ib clinical trial of...ide polymerase inhibitor. ANA598 was very well-to...
(Date:1/7/2009)...eral Products in Development Based On Osteotech,s ... Natural BioRegeneration; FDA Filing Anticipated i... 7 Osteotech, Inc. (Na...biologic products for regenerative healing, announ... trial for its DuraTech(TM) BioRegeneration Matrix...
(Date:1/6/2009)...., Jan. 6 In recent controlled stu... of Memphis , scientists found that the patented i...irst and only proven ingredient to increase levels...ing blood nitrate/nitrate (NOx) in human subjects....bles an increase in blood flow to the skeletal mus...
(Date:1/6/2009)...rance, January 6 , ...ollaboration Until,December 2011 , - Expan...Antibody,Discovery in Ophthalmology , - Re...Allergan,Sublicenses to a Third Party , ...unced a reinforcement,of its existing drug discov...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4US Oncology Announces Resignation of Chief Financial Officer 4706 1Talk Therapy Proves Effective for Terminal Cancer Patients 17223 1Talk Therapy Proves Effective for Terminal Cancer Patients 17223 2Masimo to Report First Quarter 2008 Financial Results on April 29 2008 17220 1Masimo to Report First Quarter 2008 Financial Results on April 29 2008 17220 221st Congress of the College of Neuropsychopharmacology 17215 121st Congress of the College of Neuropsychopharmacology 17215 2
...ger, M.D., Ph.D. Contributing Editor Harvard Medic...art failure in African American patients has under...ifferently to the same medication. This concept h...ns, and in many cases is due to individual genetic...ses on these issues, valuable new laboratory tools...
.... Contributing Editor The outcome of many illnesse... units (ICUs) has not improved dramatically over t...ech monitors and sophisticated mechanical and phar...d, critically ill patients requiring intensive car...f death and substantial morbidity. Recently, howe...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3
...ive base of experience and knowledge in the use of...gous platelets are mixed with calcified thrombin a...ved in coagulation take place. Secreted from the p...in, fibronectin, adenosine diphosphate, thromboxan...
Sony DVD Recorder for recording and playback of DVD video discs to complement DP micro video cameras.
...s a 3 CCD 1/3 inch camera that is ideal for micros...n of 800 TV lines and a S/N ratio of 62dB. It is a...The camera incorporates HAD technology that greatl.... The camera features powerful picture contrast co...
...and VTR's that are specially designed for use in m... radiology and operating theater monitoring. The S...ol via RS-232. Their family of products offer seve...digital or analog recording you are looking for, S...
Medicine Products: